Vorinostat Can Reduce an Ongoing Fibrosis and Preserve Key Liver Metabolic Functions by Selectively Altering Mesenchymal Cell Differentiation
Liver fibrosis is a major global cause of mortality that is driven by the activation of hepatic stellate cells (HSCs) into extracellular matrix (ECM)-produ